Sparkle Clean Tech Licenses Oil & Gas Water Treatment Technologies from Siemens Energy, Inc.
20.1.2025 12:03:00 CET | Business Wire | Press release
This License expands Sparkle's portfolio for sustainable, integrated water solutions that support oil and gas exploration and production and support customers' waste and efficiency goals.
Sparkle Clean Tech, a global provider of process technologies and value-driven energy solutions for upstream Oil and Gas customers, is pleased to announce that it has reached an agreement with Siemens Energy to license Intellectual Property from their upstream oil and gas related water solutions technology portfolio. The license includes technologies for primary, secondary and tertiary oily water treatment, such as Corrugated Plates, Hydrocyclones, Flotation Units, Walnut Shell filters, as well as regenerable membrane-based treatment technologies. This license includes intellectual property such as patents, copyrights and trade secrets. The technologies effectively address the water and wastewater needs of the oil and gas industry.
Sparkle Clean Tech will license Siemens Energy's Monosep™ Nutshell Filtration; Perfomedia™ adsorption technology; Veirsep™ and Spinsep™ Flotation with Brise DGF Pumps or Eductors; FoldedFlo™ DAF; Liquid/Liquid Hydro cyclones with TL1.05™ Liners; and Corrugated Plate separators, along with the associated intellectual property.
The integration of these technologies will expand Sparkle Clean Tech's portfolio of sustainable and integrated offerings into the treatment of water and wastewater produced in Oil & Gas exploration and production facilities.
Mike Foster, Director of Sparkle Clean Tech, stated, "Water and wastewater management in Oil & Gas exploration and production is critical for our customers who are looking for answers to improve efficiency, make their operations more sustainable, and comply with environmental regulations and standards. This license adds to our growing integrated technology portfolio and provides yet another sustainable solution for our customers."
Sumeet Mehra, CEO Sparkle Clean Tech, stated further "We are thrilled to announce the licence of Siemens Energy's oil and gas water and wastewater treatment technologies. This strategic move reinforces our commitment to providing comprehensive and sustainable solutions to our customers in the oil and gas industry. The addition of these cutting-edge technologies to our portfolio not only expands our capabilities but also strengthens our position as a leader in integrated water solutions. We are confident that these licenses will play a significant role in supporting our customers' waste and efficiency goals while contributing to the preservation of our environment."
The licensed portfolio of technologies focuses on the treatment of oil & gas wastewater from production wells, while the Brise & Perfomedia process offers an efficient wastewater treatment solution designed to remove pollutants from produced wastewater. Both processes offer significant advancements in waste management within the oil and gas industry.
Sparkle Clean Tech is committed to driving innovation and sustainability within the oil and gas sector. By licensing Siemens Energy's upstream water treatment technologies, Sparkle Clean Tech aims to offer comprehensive solutions that support customers' waste and efficiency goals, while also contributing to environmental preservation.
About Sparkle Clean Tech:
Sparkle Clean Tech is a global provider of process technologies and value-driven energy solutions for upstream Oil and Gas customers. With a focus on sustainability and innovation, Sparkle Clean Tech aims to optimize operations and support customers' environmental goals while driving efficiency and profitability.
Sparkle Clean Tech’s other solutions include treatment technologies for water and wastewater management. Utilizing specialized Ultrafiltration, Reverse Osmosis, Desalination, and High Purity Water technologies, Sparkle addresses the needs of diverse industries including Lithium, Microelectronics, Mining among others. With a global customer footprint, Sparkle has executed several projects in the Americas, Europe, Asia, and the Middle East.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250120193068/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hisense Delivers 38% Sales Uplift in Western Europe Markets With NIQ’s AI-Powered Market Intelligence6.5.2026 05:00:00 CEST | Press release
NIQ insights drive international expansion and measurable growth for Hisense across key global markets NIQ (NYSE: NIQ), a global leader in consumer intelligence, today shared new learnings from its long-standing collaboration with Hisense, a leading global brand in home appliances and smart technologies. Using NIQ’s AI‑powered market intelligence, Hisense has accelerated international expansion, improved local market decision-making, and delivered measurable growth across more than 20 key markets and 12+ categories. The case study demonstrates how AI‑driven insights help global brands move faster, localize better, and compete more effectively in complex markets. The Challenge As Hisense expanded internationally, it faced rising complexity across global markets. Consumer preferences differed sharply across regions such as Western Europe, Eastern Europe, and Latin America, making a one‑size‑fits‑all approach ineffective. NIQ’s AI‑powered intelligence delivered the local market depth need
Samsung Bioepis Announces Positive Preliminary Phase 1 Data for SB27, Proposed Biosimilar to Keytruda (Pembrolizumab)6.5.2026 01:00:00 CEST | Press release
Phase 1 study has demonstrated pharmacokinetics (PK) equivalence between SB27 and KeytrudaPhase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 study on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), has met its primary pharmacokinetics (PK) endpoints. The randomized, double-blind, three-arm, parallel group, multicenter clinical trial demonstrated pharmacokinetic bioequivalence of SB27 (pembrolizumab) to the reference product Keytruda. Initiated in January 2024, Phase 1 study is being conducted in four countries, and is expected to be completed by November 2026.2 The study assessed pharmacokinetics, efficacy, safety, and immunogenicity of SB27, EU-sourced Keytruda, and US-sourced Keytruda in patients with stage II or IIIA non-small cell lung cancer (NSCLC) following complete resection and adjuvant platinum-based chemotherapy. 163 participants were randomized to receive SB27, EU-sourced Keytruda, or US-sour
Megaport Launches Built-In DDoS Protection Enabling On-Demand Network Resilience6.5.2026 00:00:00 CEST | Press release
Megaport DDoS Protection removes the trade-off between security, performance, and cost, offering rapid enterprise-grade mitigation. Megaport Limited (ASX: MP1) (“Megaport”), a leading global automated infrastructure platform, today announced the launch of Megaport DDoS Protection. This new, built-in security capability for Megaport Internet allows customers to filter malicious traffic directly within the Megaport network rather than routing it through a separate or external service, for mission-critical uptime without introducing additional latency or routing complexity. As enterprises increasingly migrate to distributed cloud environments, traditional DDoS mitigation has struggled to keep pace with cloud and distributed infrastructure adoption. Standard ISP solutions often resort to dropping all traffic and taking the service offline to protect the network, while external third-party providers force a "security detour" that reroutes traffic through public infrastructure, introducing s
IFF Reports First Quarter 2026 Results5.5.2026 22:23:00 CEST | Press release
Delivered solid top and bottom line Q1 resultsProgressing disciplined sale process for Food Ingredients businessReaffirms Full Year 2026 Financial Guidance IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Consolidated Summary: Management Commentary “IFF is off to a solid start in 2026, with first quarter results that reflect the customer focus and operational execution we’ve been building across the company,” said Erik Fyrwald, CEO of IFF. “We delivered volume growth in all four segments, improved profitability, and generated strong cash flow in the first quarter. As we look ahead, we are maintaining a disciplined approach to how we are planning the balance of the year as the current operating environment remains unsettled. We remained focused on advancing our commercial and innovation pipelines, driving productivity, and working with customers to offset inflation. This – when combined with our solid start to the year – derisks t
Logitech Announces Q4 and Full Fiscal Year 2026 Results5.5.2026 22:06:00 CEST | Press release
Strong FY 2026 Demonstrates Strategy and Operating Principles Are Delivering SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2026. For Fiscal Year 2026: Sales were $4.84 billion, up 6 percent in US dollars and 4 percent in constant currency compared to the prior year. GAAP operating income was $775 million, up 18 percent compared to the prior year. Non-GAAP operating income was $911 million, up 18 percent compared to the prior year. GAAP earnings per share was $4.80, up 16 percent compared to the prior year. Non-GAAP EPS was $5.78, up 19 percent compared to the prior year. Cash flow from operations was $1.04 billion. The year-ending cash balance was $1.7 billion. The Company returned $768 million of cash to shareholders through its annual dividend payment and share repurchases. For Q4 Fiscal Year 2026: Sales were $1.09 billion, up 7 percent in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom